AGP Executive Report
Last update: 3 hours agoEbola Surge & Community Response: DR Congo’s Ebola outbreak has passed 4,000 confirmed cases (about 4,053) with roughly 1,850 deaths, as Africa CDC and WHO push for a village-led response, faster testing and care, and stronger support for frontline workers amid insecurity and misinformation. Vaccine Strategy Shift: WHO advisors say a licensed Zaire Ebola vaccine (Merck’s Ervebo) could be used as a stop-gap while research checks whether the current Bundibugyo strain is changing. Kinshasa River Alerts: Health teams intercepted boats near Kinshasa and tested passengers after suspected Ebola deaths; recent checks reported negative results for some screened travelers, but authorities keep expanding screening. Contact Tracing Failing: Africa CDC says contact tracing isn’t working well because many new cases are emerging through community spread. Minerals Policy & Tech: Kinshasa ordered an immediate halt to exporting copper and cobalt concentrates to keep more value in-country, while Congo also says it will investigate uranium claims tied to cobalt shipments to China. Mpox Vaccine Access: The EU authorized an mpox vaccine for children aged 2 to under 12, aiming to close a major DRC pediatric gap.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
